Economic Outcomes Associated with the Use of Risperidone in a Naturalistic Group Practice Setting

Brian S. Nightengale, PhD;Linda Garrett, MS;Susie Waugh, RN;Bryan J. Lawrence, PharmD;John Andrus, MD;

Publication

Article

March 1, 1998

The American Journal of Managed Care

March 1998

Volume4

Issue 3

Economic Outcomes Associated with the Use of Risperidone in a Naturalistic Group Practice Setting

Author(s):

Brian S. Nightengale, PhD,Linda Garrett, MS

Download PDF: Economic Outcomes Associated with the Use of Risperidone in a Naturalistic Group Practice Setting

Articles in this issue

Identifying Diabetes Mellitus or Heart Disease Among Health Maintenance Organization Members: Sensitivity, Specificity, Predictive Value, and Cost of Survey and Database Methods

A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia

Economic Outcomes Associated with the Use of Risperidone in a Naturalistic Group Practice Setting

Treatment of Schizophrenia: Let's Talk Dollars and Sense

Maintaining Skeletal Health Among Postmenopausal Women

Prevalence and Cost of Hospitalization for Gastrointestinal Complications Related to Peptic Ulcers with Bleeding or Perforation: Comparison of Two National Databases

Virtual Managed Care Organizations: The Implications of Technology-Based Patient Management

Work-up for Diverticulitis

Screening and Surveillance for Colorectal Cancer

Parenteral and Enteral Nutrition in the Home and Chronic Care Settings

Related Content

May 16th 2025

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

Ofer Kobo, MD Martin K. Rutter, MD Shivani Misra, PhD Erin D. Michos, MD, MHS Phyo K. Myint, MD Ariel Roguin, MD, PhD Louise Y. Sun, MD Mamas A. Mamas, MD

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.

May 15th 2025

Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits

Portia J. Zaire, PhD, RN A. Mark Fendrick, MD Jacob E. Kurlander, MD, MS Archana Radhakrishnan, MD, MHS

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population health for all stakeholders.

May 14th 2025

Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives

Katarina Wang, BS Ann Marie Hernandez, MD, MPH Veronica Penate, BS Anshu Abhat, MD, MPH Alejandra Casillas, MD, MSHS

Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.

May 13th 2025

Using Data Exchange to Improve Quality Reporting, Target Outreach, and Reduce Cost

Barbara Rubino, MD Chelsea Hart-Connor, MA Todd A. May, MD

Covered California and Health Net’s novel data exchange initiative significantly improved quality measurement and potentially reduced costs by more than $640,000.

May 12th 2025

Effects of Maryland’s All-Payer Model on Elective Joint Replacement Surgery

Meiling Ying, PhD Addison Shay, MS John M. Hollingsworth, MD, MS Vahakn B. Shahinian, MD Richard A. Hirth, PhD Brent K. Hollenbeck, MD, MS

The Maryland All-Payer Model was associated with an increase in population-based rates of elective major joint replacements, with a more pronounced effect observed in Maryland-only hospitals.

May 9th 2025

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Kenneth Cohen, MD Boris Vabson, PhD Jennifer Podulka, MPAff Omid Ameli, MD, DrPH Kierstin Catlett, PhD Nathan Smith, PhD Megan S. Jarvis, MS Jane Sullivan, MPH Caroline Goldzweig, MD, MSHS Susan Dentzer, MS

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.

Related Content

May 16th 2025

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

Ofer Kobo, MD Martin K. Rutter, MD Shivani Misra, PhD Erin D. Michos, MD, MHS Phyo K. Myint, MD Ariel Roguin, MD, PhD Louise Y. Sun, MD Mamas A. Mamas, MD

May 15th 2025

Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits

Portia J. Zaire, PhD, RN A. Mark Fendrick, MD Jacob E. Kurlander, MD, MS Archana Radhakrishnan, MD, MHS

May 14th 2025

Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives

Katarina Wang, BS Ann Marie Hernandez, MD, MPH Veronica Penate, BS Anshu Abhat, MD, MPH Alejandra Casillas, MD, MSHS

Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.

May 13th 2025

Using Data Exchange to Improve Quality Reporting, Target Outreach, and Reduce Cost

Barbara Rubino, MD Chelsea Hart-Connor, MA Todd A. May, MD

Covered California and Health Net’s novel data exchange initiative significantly improved quality measurement and potentially reduced costs by more than $640,000.

May 12th 2025

Effects of Maryland’s All-Payer Model on Elective Joint Replacement Surgery

Meiling Ying, PhD Addison Shay, MS John M. Hollingsworth, MD, MS Vahakn B. Shahinian, MD Richard A. Hirth, PhD Brent K. Hollenbeck, MD, MS

The Maryland All-Payer Model was associated with an increase in population-based rates of elective major joint replacements, with a more pronounced effect observed in Maryland-only hospitals.

May 9th 2025

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions